Dajia Weikang: Announcement on the progress of external guarantees
Securities code: 301126 Securities abbreviation: Dajia Weikang Announcement number: 2026-041
Hunan Dajia Weikang Pharmaceutical Industry Co., Ltd.
Announcement on the progress of external guarantees
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete, and contains no false records, misleading statements or major omissions.
1. Overview of guarantee situation
In order to meet the daily production, operation and business development capital needs of the company's wholly-owned subsidiaries and holding subsidiaries, Hunan Dajia Weikang Pharmaceutical Industry Co., Ltd. (hereinafter referred to as the "Company") and ensure the smooth development of the company's business, the company announced on April 24, 2026 and May 19, 2026 The 19th meeting of the fourth board of directors and the 2025 annual shareholders' meeting held respectively on the same day reviewed and approved the "Proposal on the Estimated Guarantee Amount for 2026", agreeing that the company will provide guarantees for the company's wholly-owned subsidiaries and controlled subsidiaries in 2026, and the guarantee amount is expected to not exceed 2.5 billion yuan. For details, please refer to the "Announcement on the Estimated Guarantee Amount for 2026" disclosed by the company on the cninfo.com (http://www.cninfo.com.cn) on April 28, 2026 (announcement number: 2026-014).
2. Progress of external guarantees
Recently, the company signed the "Changsha Bank Maximum Guarantee Contract" with Changsha Bank Co., Ltd. (hereinafter referred to as "Changsha Bank"), agreeing to jointly provide a total amount of RMB 16,000 to its wholly-owned subsidiary Hunan Dajia Weikang Pharmaceutical Co., Ltd. (hereinafter referred to as "Dajia Pharmaceutical") A guarantee of RMB 10,000; the company signed a "Liquid Capital Loan Contract" with Guyuan Branch of Shizuishan Bank Co., Ltd. (hereinafter referred to as "Shizuishan Bank") and agreed to provide a total amount of RMB 2,000 to its holding subsidiary Ningxia Delixin Pharmaceutical Co., Ltd. (hereinafter referred to as "Ningxia Delixin") The company has signed a "Maximum Guarantee Contract" with Datong Branch of Industrial Bank Co., Ltd. (hereinafter referred to as "Industrial Bank") respectively, agreeing to provide 10 stores (Shanxi Simile Pharmaceutical Chain Co., Ltd. Datong Beichen Garden Store, Shanxi Simile Pharmaceutical Chain Co., Ltd. Datong Fuxi Store, Shanxi Simile Pharmaceutical Chain Co., Ltd. Datong Jinxiang Store, Shanxi Simile Pharmaceutical Chain Co., Ltd. Datong Jinxiang Store, Shanxi Simile Pharmaceutical Chain Co., Ltd.) under its holding subsidiary Shanxi Simile Pharmaceutical Chain Co., Ltd. (hereinafter referred to as "Shanxi Simile"). West Simile Pharmaceutical Chain Co., Ltd. Datong Bureau East Store, Shanxi Simile Pharmaceutical Chain Co., Ltd. Datong Shuiquanwan Longyuan Store, Shanxi Simile Pharmaceutical Chain Co., Ltd. Datong Sun City Store, Shanxi Simile Pharmaceutical Chain Co., Ltd. Datong Tongquanli Store, Shanxi Simile Pharmaceutical Chain Co., Ltd. Datong Yingbinyuan Store, Shanxi Simile Pharmaceutical Chain Co., Ltd. Datong Yingze East Street Store, Shanxi Simile Pharmaceutical Chain Co., Ltd. Datong Yonghe Road Store) provide a total amount of RMB 2,840 Ten thousand yuan guaranteed guarantee.
3. Basic information of the guaranteed person
(1) Guaranteed person: Hunan Dajia Weikang Pharmaceutical Co., Ltd.
Unified social credit code: 914300007632532092
Registered address: No. 30 Fuling Road, Yuelu District, Changsha City
Registered capital: 330.200005 yuan
Legal representative: Wang Yiqing
Date of establishment: June 1, 2004
Business scope: Licensed items: pharmaceutical production (excluding the application of processing technologies such as steaming, stir-frying, broiling, and calcining of traditional Chinese medicine pieces and the production of confidential prescription products of proprietary Chinese medicines); pharmaceutical wholesale; food sales; bonded logistics center operations; urban distribution and transportation services (excluding dangerous goods); pharmaceutical retail; pharmaceutical import and export; road cargo transportation (excluding dangerous goods); third-category medical device operations. (Projects that require approval according to law can only be carried out with the approval of relevant departments. Specific business projects are subject to the approval documents or licenses of relevant departments) General projects: operation of road cargo transportation stations; sales of formula foods for special medical purposes; sales of infant formula milk powder and other infant formula foods; health food Sales of products (prepackaged); sales of sanitary products and disposable medical supplies; retail of cosmetics; retail of hardware products; retail of sporting goods and equipment; retail of medical masks; retail of protective supplies for medical staff; wholesale of protective supplies for medical staff; wholesale of medical masks; repair of special equipment; sales of second-class medical devices; Software development; sales of application instruments; sales of glass fiber reinforced plastic products; domestic container cargo transportation agency; medical research and experimental development; information consulting services (excluding licensing information consulting services); technical services, technology development, technical consultation, technology exchange, technology transfer, technology promotion; information Technical consulting services; digital technology services; conference and exhibition services; non-residential real estate leasing; sales of Class I medical devices; import and export of food; import and export of goods; general cargo warehousing services (excluding hazardous chemicals and other items that require license approval); low-temperature warehousing (excluding hazardous chemicals and other items that require license and approval). (Except for projects that require approval according to law, business activities can be carried out independently with a business license and in accordance with the law)
Dajia Pharmaceutical is not one of the persons subject to execution for breach of trust.
Relationship with listed companies: Dajia Pharmaceutical is a wholly-owned subsidiary of the company, and the company holds 100% of the shares.
Dajia Pharmaceutical’s main financial data for the latest year:
Unit: Yuan account December 31, 2025 (audited) March 31, 2026 (unaudited) Total assets 3,722,383,738.52 3,884,614,419.70 Total liabilities 2,865,323,086.14 2,924,677,408.69 Net assets 857,060,652.38 959,937,011.01 Account 2025 (audited) January-March 2026 (unaudited) operating income 2,836,066,824.16 749,433,769.89Total profit -130,590,554.85 -12,355,219.12Net profit -115,118,197.75 -9,758,854.34
(2) Guaranteed person: Ningxia Delixin Pharmaceutical Co., Ltd.
Unified social credit code: 916404047999088796
Registered address: No. 13, Center Road, Qingshuihe Industrial Park, Economic Development Zone, Guyuan City, Ningxia
Registered capital: 8 million yuan
Legal representative: Duan Junzhang
Date of establishment: April 4, 2007
Business scope: Licensed items: wholesale of medicines; retail of medicines; sales of medicinal excipients; third-category medical device operations; sales of sterilization equipment; Internet sales of food; food sales; alcohol operations; first-class value-added telecommunications business; second-category value-added telecommunications business; Internet information services; pharmaceutical Internet information services; Chinese medicine slice decoction services; medical device Internet information services; urban distribution and transportation services (excluding dangerous goods) ; Internet live broadcast technical services (projects that must be approved according to law, business activities can only be carried out after approval by relevant departments) General projects: sales of first-class medical devices; sales of second-class medical devices; wholesale of protective supplies for medical staff; sales of daily masks (non-medical); sales of disinfectants (excluding hazardous chemicals); sales of sanitary products and disposable medical supplies; sales of special labor protection supplies; sales of labor protection supplies; daily use Sales of department stores; wholesale of cosmetics; sales of personal hygiene products; sales of maternal and infant products; sales of glasses (excluding contact lenses); sales of hygienic pesticides; sales of food detergents; wholesale of sporting goods and equipment; wholesale of edible agricultural products; sales of electronic products; Internet sales of food (only sales of prepackaged food); Internet sales (except for the sale of goods that require a license); Traditional Chinese medicine clinic services (must be registered with the competent department of traditional Chinese medicine before being licensed) business activities); health care services (non-medical); traditional Chinese medicine health care services (non-medical); non-residential real estate leasing; Class I medical equipment leasing; Class II medical equipment leasing; real estate Chinese herbal medicine (excluding Chinese herbal medicine pieces) purchase and sale; health consulting services (excluding diagnosis and treatment services); remote health management services; corporate membership points management services; general cargo warehousing services (excluding hazardous chemicals and other items requiring license approval). (Except for licensed business, you can independently operate projects that are not prohibited or restricted by laws and regulations in accordance with the law)
Ningxia Delixin is not a person subject to execution for breach of trust.
Relationship with listed companies: Ningxia Delixin is a holding subsidiary of the company, with the company holding 51% of the shares.
Ningxia Delixin’s main financial data for the latest year:
Unit: Yuan account December 31, 2025 (audited) March 31, 2026 (unaudited) Total assets 494,086,239.69 390,051,273.53 Total liabilities 436,808,191.55 334,926,844.34 Net assets 57,278,048.14 55,124,429.19 Item 2025 (audited) January-March 2026 (unaudited) operating income 464,133,112.31 58,960,807.89 Total profit -8,027,841.41 612,190.28 Net profit -8,953,315.57 527,999.72
(3) Guaranteed person: 10 stores under Shanxi Simile Pharmaceutical Chain Co., Ltd. (Shanxi Simile Pharmaceutical Chain Co., Ltd. Datong Beichen Garden Store, Shanxi Simile Pharmaceutical Chain Co., Ltd. Datongfu West Store, Shanxi Simile Pharmaceutical Chain Co., Ltd. Datong Jinxiang Store, Shanxi Simile Pharmaceutical Chain Co., Ltd. Datong Bureau East Store, Shanxi Simile Pharmaceutical Chain Co., Ltd. Datong Shuiquanwan Longyuan Store, Shanxi Simile Pharmaceutical Chain Co., Ltd. Datong Sun City Store, Shanxi Simile Pharmaceutical Chain Co., Ltd. Datong Tongquanli Store, Shanxi Simile Pharmaceutical Chain Co., Ltd. Datong Yingbinyuan Store, Shanxi Simile Pharmaceutical Chain Co., Ltd. Datong Yingze East Street Store, Shanxi Simile Pharmaceutical Chain Co., Ltd. Datong Yonghe Road Store)
- Shanxi Simile Pharmaceutical Chain Co., Ltd. Datong Beichen Garden Store
(1) Unified social credit code: 91140200MA0MA5E04U
(2) Registered address: No. 9, Floor 1 to 2, Neighbor Street Shop, District 3, Beichen Garden, east of Beiyuan Road, Pingcheng District, Datong City, Shanxi Province
(3) Person in charge: An Xuefeng
(4) Date of establishment: August 12, 2021
(5) Business scope: Licensed items: drug retail; drug Internet information services; medical device Internet information services; third-class medical device operations; e-cigarette retail. (Items that require approval according to law can only be carried out after approval by relevant departments. Specific business items are subject to approval documents or licenses from relevant departments.) General items: sales of health food (prepackaged); sales of food (only sales of prepackaged food); sales of first-class medical devices; sales of second-class medical devices; sales of daily necessities; sales of disinfectants (excluding hazardous chemicals); sales of agricultural and sideline products; sales of household appliances; sales of glasses (excluding contact lenses); sales of office supplies; retail of cosmetics; sales of labor protection supplies Retail sales of sporting goods and equipment; retail sales of hardware products; sales of metal materials; sales of building materials; sales of plastic products; sales of rubber products; sales of communication equipment; sales of furniture; retail of stationery; sales of arts and crafts and ceremonial items (except ivory and their products); sales of metal structures; retail sales of clothing and apparel; retail sales of shoes and hats; sales of knitted textiles; sales of leather products; sales of gifts and flowers; Internet sales of food (only sales of prepackaged food); sales of single-purpose commercial prepaid cards; agency sales of takeaway delivery services; repair of special equipment. (Except for projects that require approval according to law, business activities can be carried out independently with a business license and in accordance with the law)
(6) Datong Beichen Garden Store of Shanxi Simile Pharmaceutical Chain Co., Ltd. is not a person subject to execution for breach of trust.
(7) Relationship with listed companies: Datong Beichen Garden Store of Shanxi Simile Pharmaceutical Chain Co., Ltd. is a direct-operated store of Shanxi Simile, a subsidiary of the company, and the company holds 51% of the equity of Shanxi Simile.
- Shanxi Simile Pharmaceutical Chain Co., Ltd. Datongfu West Store
(1) Unified social credit code: 91140200MA0MA9UN5C
(2) Registered address: Shop No. 49, Community Phase I and II, Shantytown, Yungang District, Datong City, Shanxi Province
(3) Person in charge: An Xuefeng
(4) Date of establishment: August 17, 2021
(5) Business scope: Licensed items: drug retail; drug Internet information services; medical device Internet information services; third-class medical device operations; e-cigarette retail. (Items that require approval according to law can only be carried out after approval by relevant departments. Specific business items are subject to approval documents or licenses from relevant departments.) General items: sales of health food (prepackaged); sales of food (only sales of prepackaged food); sales of first-class medical devices; sales of second-class medical devices; sales of daily necessities; sales of disinfectants (excluding hazardous chemicals); sales of agricultural and sideline products; sales of household appliances; sales of glasses (excluding contact lenses); sales of office supplies; retail of cosmetics; sales of labor protection supplies Retail sales of sporting goods and equipment; retail sales of hardware products; sales of metal materials; sales of building materials; sales of plastic products; sales of rubber products; sales of communication equipment; sales of furniture; retail of stationery; sales of arts and crafts and ceremonial items (except ivory and their products); sales of metal structures; retail sales of clothing and apparel; retail sales of shoes and hats; sales of knitted textiles; sales of leather products; sales of gifts and flowers; Internet sales of food (only sales of prepackaged food); sales of single-purpose commercial prepaid cards; agency sales of takeaway delivery services; repair of special equipment. (Except for projects that require approval according to law, business activities can be carried out independently with a business license and in accordance with the law)
(6) Shanxi Simile Pharmaceutical Chain Co., Ltd. Datong Fuxi Store is not a person subject to execution for breach of trust.
(7) Relationship with listed companies: Datong Fuxi Store of Shanxi Simile Pharmaceutical Chain Co., Ltd. is a direct-operated store of Shanxi Simile, a subsidiary of the company, and the company holds 51% of the equity of Shanxi Simile.
- Shanxi Simile Pharmaceutical Chain Co., Ltd. Datong Jinxiang Store
(1) Unified social credit code: 91140200MA0MA0F90A
(2) Registered address: No. 3, Jinxiang Community Shop, Weidu Avenue, Pingcheng District, Datong City, Shanxi Province
(3) Person in charge: An Xuefeng
(4) Date of establishment: August 9, 2021
(5) Business scope: Licensed items: drug retail; drug Internet information services; medical device Internet information services; third-class medical device operations; e-cigarette retail. (Items that require approval according to law can only be carried out after approval by relevant departments. Specific business items are subject to approval documents or licenses from relevant departments.) General items: sales of health food (prepackaged); sales of food (only sales of prepackaged food); sales of first-class medical devices; sales of second-class medical devices; sales of daily necessities; sales of disinfectants (excluding hazardous chemicals); sales of agricultural and sideline products; sales of household appliances; sales of glasses (excluding contact lenses); sales of office supplies; retail of cosmetics; labor Sales of animal protection products; retail of sporting goods and equipment; retail of hardware products; sales of metal materials; sales of building materials; sales of plastic products; sales of rubber products; sales of communication equipment; sales of furniture; retail of stationery; sales of arts and crafts and ceremonial items (except ivory and its products); sales of metal structures; retail of clothing and apparel; retail of shoes and hats; sales of knitted textiles; sales of leather products; sales of gifts and flowers; graphic design; agency sales of single-purpose commercial prepaid cards; takeaway delivery services; repair of special equipment. (Except for projects that require approval according to law, business activities can be carried out independently with a business license and in accordance with the law)
(6) Datong Jinxiang Store of Shanxi Simile Pharmaceutical Chain Co., Ltd. is not a person subject to execution for breach of trust.
(7) Relationship with listed companies: Datong Jinxiang Store of Shanxi Simile Pharmaceutical Chain Co., Ltd. is a direct-operated store of Shanxi Simile, a subsidiary of the company, and the company holds 51% of the equity of Shanxi Simile.
- Shanxi Simile Pharmaceutical Chain Co., Ltd. Datong Bureau East Store
(1) Unified social credit code: 91140200MA0MA6XD4M
(2) Registered address: Shop No. 13, South Courtyard, Xinhua Street, Pingcheng District, Datong City, Shanxi Province
(3) Person in charge: An Xuefeng
(4) Date of establishment: August 13, 2021
(5) Business scope: Licensed items: drug retail; drug Internet information services; medical device Internet information services; third-class medical device operations; e-cigarette retail. (Items that require approval according to law can only be carried out after approval by relevant departments. Specific business items are subject to approval documents or licenses from relevant departments.) General items: sales of health food (prepackaged); sales of food (only sales of prepackaged food); sales of first-class medical devices; sales of second-class medical devices; sales of daily necessities; sales of disinfectants (excluding hazardous chemicals); sales of agricultural and sideline products; sales of household appliances; sales of glasses (excluding contact lenses); sales of office supplies; retail of cosmetics; sales of labor protection supplies Retail sales of sporting goods and equipment; retail sales of hardware products; sales of metal materials; sales of building materials; sales of plastic products; sales of rubber products; sales of communication equipment; sales of furniture; retail of stationery; sales of arts and crafts and ceremonial items (except ivory and their products); sales of metal structures; retail sales of clothing and apparel; retail sales of shoes and hats; sales of knitted textiles; sales of leather products; sales of gifts and flowers; Internet sales of food (only sales of prepackaged food); sales of single-purpose commercial prepaid cards; agency sales of takeaway delivery services; repair of special equipment. (Except for projects that require approval according to law, business activities can be carried out independently with a business license and in accordance with the law)
(6) Datong Bureau East Store of Shanxi Simile Pharmaceutical Chain Co., Ltd. is not the person subject to execution for breach of trust.
(7) Relationship with listed companies: The Datong Bureau East Store of Shanxi Simile Pharmaceutical Chain Co., Ltd. is a direct-operated store of Shanxi Simile, a subsidiary of the company, and the company holds 51% of the equity of Shanxi Simile.
- Shanxi Simile Pharmaceutical Chain Co., Ltd. Datong Shuiquanwan Longyuan Store
(1) Unified social credit code: 91140200MA0MA3WX3P
(2) Registered address: Shop No. 6, Floor 1, Area A, Longyuan, Shuiquanwan, east of Yuhe West Road, Pingcheng District, Datong City, Shanxi Province (3) Person in charge: An Xuefeng
(4) Date of establishment: August 11, 2021
(5) Business scope: Licensed items: drug retail; drug Internet information services; medical device Internet information services; third-class medical device operations; e-cigarette retail. (Items that require approval according to law can only be carried out after approval by relevant departments. Specific business items are subject to approval documents or licenses from relevant departments.) General items: sales of health food (prepackaged); sales of food (only sales of prepackaged food); sales of first-class medical devices; sales of second-class medical devices; sales of daily necessities; sales of disinfectants (excluding hazardous chemicals); sales of agricultural and sideline products; sales of household appliances; sales of glasses (excluding contact lenses); sales of office supplies; retail of cosmetics; sales of labor protection supplies Retail sales of sporting goods and equipment; retail sales of hardware products; sales of metal materials; sales of building materials; sales of plastic products; sales of rubber products; sales of communication equipment; sales of furniture; retail of stationery; sales of arts and crafts and ceremonial items (except ivory and their products); sales of metal structures; retail sales of clothing and apparel; retail sales of shoes and hats; sales of knitted textiles; sales of leather products; sales of gifts and flowers; Internet sales of food (only sales of prepackaged food); sales of single-purpose commercial prepaid cards; agency sales of takeaway delivery services; repair of special equipment. (Except for projects that require approval according to law, business activities can be carried out independently with a business license and in accordance with the law)
(6) Datong Shuiquanwan Longyuan Store of Shanxi Simile Pharmaceutical Chain Co., Ltd. is not a person subject to execution for breach of trust.
(7) Relationship with listed companies: Datong Shuiquanwan Longyuan Store of Shanxi Simile Pharmaceutical Chain Co., Ltd. is a direct-operated store of Shanxi Simile, a subsidiary of the company, and the company holds 51% of the equity of Shanxi Simile.
- Shanxi Simile Pharmaceutical Chain Co., Ltd. Datong Sun City Store
(1) Unified social credit code: 91140200MA0MA5B80N
(2) Registered address: Shop No. 3-10, Sun City Phase II, Pingcheng District, Datong City, Shanxi Province
(3) Person in charge: An Xuefeng
(4) Date of establishment: August 12, 2021
(5) Business scope: Licensed items: drug retail; drug Internet information services; medical device Internet information services; third-class medical device operations; e-cigarette retail. (Items that require approval according to law can only be carried out after approval by relevant departments. Specific business items are subject to approval documents or licenses from relevant departments.) General items: sales of health food (prepackaged); sales of food (only sales of prepackaged food); sales of first-class medical devices; sales of second-class medical devices; sales of daily necessities; sales of disinfectants (excluding hazardous chemicals); sales of agricultural and sideline products; sales of household appliances; sales of glasses (excluding contact lenses); sales of office supplies; retail of cosmetics; sales of labor protection supplies Retail sales of sporting goods and equipment; retail sales of hardware products; sales of metal materials; sales of building materials; sales of plastic products; sales of rubber products; sales of communication equipment; sales of furniture; retail of stationery; sales of arts and crafts and ceremonial items (except ivory and their products); sales of metal structures; retail sales of clothing and apparel; retail sales of shoes and hats; sales of knitted textiles; sales of leather products; sales of gifts and flowers; Internet sales of food (only sales of prepackaged food); sales of single-purpose commercial prepaid cards; agency sales of takeaway delivery services; repair of special equipment. (Except for projects that require approval according to law, business activities can be carried out independently with a business license and in accordance with the law)
(6) Shanxi Simile Pharmaceutical Chain Co., Ltd. Datong Sun City Store is not a person subject to execution for breach of trust.
(7) Relationship with listed companies: Shanxi Simile Pharmaceutical Chain Co., Ltd. Datong Sun City Store
It is a directly-operated store of Shanxi Simile, a subsidiary of the company, and the company holds 51% of the equity of Shanxi Simile.
- Shanxi Simile Pharmaceutical Chain Co., Ltd. Datong Tongquanli Store
(1) Unified social credit code: 91140200MA0MA8AY5W
(2) Registered address: Shop No. 3, Block 1, Asia Pacific International Mansion, Pingcheng District, Datong City, Shanxi Province
(3) Person in charge: An Xuefeng
(4) Date of establishment: August 16, 2021
(5) Business scope: Licensed items: drug retail; drug Internet information services; medical device Internet information services; third-class medical device operations; e-cigarette retail. (Items that require approval according to law can only be carried out after approval by relevant departments. Specific business items are subject to approval documents or licenses from relevant departments.) General items: sales of health food (prepackaged); sales of food (only sales of prepackaged food); sales of first-class medical devices; sales of second-class medical devices; sales of daily necessities; sales of disinfectants (excluding hazardous chemicals); sales of agricultural and sideline products; sales of household appliances; sales of glasses (excluding contact lenses); sales of office supplies; retail of cosmetics; sales of labor protection supplies Retail sales of sporting goods and equipment; retail sales of hardware products; sales of metal materials; sales of building materials; sales of plastic products; sales of rubber products; sales of communication equipment; sales of furniture; retail of stationery; sales of arts and crafts and ceremonial items (except ivory and their products); sales of metal structures; retail sales of clothing and apparel; retail sales of shoes and hats; sales of knitted textiles; sales of leather products; sales of gifts and flowers; Internet sales of food (only sales of prepackaged food); sales of single-purpose commercial prepaid cards; agency sales of takeaway delivery services; repair of special equipment. (Except for projects that require approval according to law, business activities can be carried out independently with a business license and in accordance with the law)
(6) Datong Tongquanli Store of Shanxi Simile Pharmaceutical Chain Co., Ltd. is not a person subject to execution for breach of trust.
(7) Relationship with listed companies: Datong Tongquanli Store of Shanxi Simile Pharmaceutical Chain Co., Ltd. is a direct-operated store of Shanxi Simile, a subsidiary of the company, and the company holds 51% of the equity of Shanxi Simile.
- Shanxi Simile Pharmaceutical Chain Co., Ltd. Datong Yingbinyuan Store
(1) Unified social credit code: 91140200MA0MA5101Q
(2) Registered address: Shop No. 14, Jinxiang Community, Pingcheng District, Datong City, Shanxi Province
(3) Person in charge: An Xuefeng
(4) Date of establishment: August 12, 2021
(5) Business scope: Licensed items: drug retail; drug Internet information services; medical device Internet information services; third-class medical device operations; e-cigarette retail. (Items that require approval according to law can only be carried out after approval by relevant departments. Specific business items are subject to approval documents or licenses from relevant departments.) General items: sales of health food (prepackaged); sales of food (only sales of prepackaged food); sales of first-class medical devices; sales of second-class medical devices; sales of daily necessities; sales of disinfectants (excluding hazardous chemicals); sales of agricultural and sideline products; sales of household appliances; sales of glasses (excluding contact lenses); sales of office supplies; retail of cosmetics; sales of labor protection supplies Retail sales of sporting goods and equipment; retail sales of hardware products; sales of metal materials; sales of building materials; sales of plastic products; sales of rubber products; sales of communication equipment; sales of furniture; retail of stationery; sales of arts and crafts and ceremonial items (except ivory and their products); sales of metal structures; retail sales of clothing and apparel; retail sales of shoes and hats; sales of knitted textiles; sales of leather products; sales of gifts and flowers; Internet sales of food (only sales of prepackaged food); sales of single-purpose commercial prepaid cards; agency sales of takeaway delivery services; repair of special equipment. (Except for projects that require approval according to law, business activities can be carried out independently with a business license and in accordance with the law)
(6) Shanxi Simile Pharmaceutical Chain Co., Ltd. Datong Yingbinyuan Store is not a person subject to execution for breach of trust.
(7) Relationship with listed companies: Datong Yingbin Park Store of Shanxi Simile Pharmaceutical Chain Co., Ltd. is a direct-operated store of Shanxi Simile, a subsidiary of the company, and the company holds 51% of the equity of Shanxi Simile.
- Shanxi Simile Pharmaceutical Chain Co., Ltd. Datong Yingze East Street Store
(1) Unified social credit code: 91140200MA0MA52084
(2) Registered address: Shop No. 13, Building 1, South Market, Yingze East Street, Pingcheng District, Datong City, Shanxi Province (3) Person in charge: An Xuefeng
(4) Date of establishment: August 12, 2021
(5) Business scope: Licensed items: drug retail; drug Internet information services; medical device Internet information services; third-class medical device operations; e-cigarette retail. (Items that require approval according to law can only be carried out after approval by relevant departments. Specific business items are subject to approval documents or licenses from relevant departments.) General items: sales of health food (prepackaged); sales of food (only sales of prepackaged food); sales of first-class medical devices; sales of second-class medical devices; sales of daily necessities; sales of disinfectants (excluding hazardous chemicals); sales of agricultural and sideline products; sales of household appliances; sales of glasses (excluding contact lenses); sales of office supplies; retail of cosmetics; sales of labor protection supplies Retail sales of sporting goods and equipment; retail sales of hardware products; sales of metal materials; sales of building materials; sales of plastic products; sales of rubber products; sales of communication equipment; sales of furniture; retail of stationery; sales of arts and crafts and ceremonial items (except ivory and their products); sales of metal structures; retail sales of clothing and apparel; retail sales of shoes and hats; sales of knitted textiles; sales of leather products; sales of gifts and flowers; Internet sales of food (only sales of prepackaged food); sales of single-purpose commercial prepaid cards; agency sales of takeaway delivery services; repair of special equipment. (Except for projects that require approval according to law, business activities can be carried out independently with a business license and in accordance with the law)
(6) Shanxi Simile Pharmaceutical Chain Co., Ltd. Datong Yingze East Street Store is not a person subject to execution for breach of trust.
(7) Relationship with listed companies: Datong Yingze East Street Store of Shanxi Simile Pharmaceutical Chain Co., Ltd. is a direct-operated store of Shanxi Simile, a subsidiary of the company, and the company holds 51% of the equity of Shanxi Simile.
- Shanxi Simile Pharmaceutical Chain Co., Ltd. Datong Yonghe Road Store
(1) Unified social credit code: 91140200MA0MA6T10U
(2) Registered address: Shop No. 97, North China Star City Phase II, Pingcheng District, Datong City, Shanxi Province
(3) Person in charge: An Xuefeng
(4) Date of establishment: August 13, 2021
(5) Business scope: Licensed items: drug retail; drug Internet information services; medical device Internet information services; third-class medical device operations; e-cigarette retail. (Items that require approval according to law can only be carried out after approval by relevant departments. Specific business items are subject to approval documents or licenses from relevant departments.) General items: sales of health food (prepackaged); sales of food (only sales of prepackaged food); sales of first-class medical devices; sales of second-class medical devices; sales of daily necessities; sales of disinfectants (excluding hazardous chemicals); sales of agricultural and sideline products; sales of household appliances; sales of glasses (excluding contact lenses); sales of office supplies; retail of cosmetics; sales of labor protection supplies Retail sales of sporting goods and equipment; retail sales of hardware products; sales of metal materials; sales of building materials; sales of plastic products; sales of rubber products; sales of communication equipment; sales of furniture; retail of stationery; sales of arts and crafts and ceremonial items (except ivory and their products); sales of metal structures; retail sales of clothing and apparel; retail sales of shoes and hats; sales of knitted textiles; sales of leather products; sales of gifts and flowers; Internet sales of food (only sales of prepackaged food); sales of single-purpose commercial prepaid cards; agency sales of takeaway delivery services; repair of special equipment. (Except for projects that require approval according to law, business activities can be carried out independently with a business license and in accordance with the law)
(6) Datong Yonghe Road Store of Shanxi Simile Pharmaceutical Chain Co., Ltd. is not a person subject to execution for breach of trust.
(7) Relationship with listed companies: The Datong Yonghe Road store of Shanxi Simile Pharmaceutical Chain Co., Ltd. is a directly-operated store of Shanxi Simile, a subsidiary of the company, and the company holds 51% of the equity of Shanxi Simile.
- Shanxi Simile’s main financial data for the latest year:
Unit: yuan account December 31, 2025 (audited) March 31, 2026 (unaudited) Total assets 406,908,543.60 443,896,334.18 Total liabilities 289,197,749.06 319,885,729.96 Net assets 117,710,794.54 124,010,604.22 Account 2025 (audited) January-March 2026 (unaudited) operating income 853,711,945.11 238,702,968.00Total profit 59,659,616.47 8,085,245.77Net profit 44,622,496.41 6,299,809.68
4. Main contents of the guarantee contract
(1) Dajia Pharmaceutical
Creditor: Changsha Bank Co., Ltd.
Debtor: Hunan Dajia Weikang Pharmaceutical Co., Ltd.
Guarantor: Hunan Dajia Weikang Pharmaceutical Industry Co., Ltd.
Guarantee method: Maximum joint and several liability guarantee
Maximum debt amount: RMB 160 million
Guarantee scope: all debts formed by the principal of the claim within the maximum claim amount, such as loan principal, exposure amount under the acceptance bill business, amount under the letter of guarantee, amount under the letter of credit, all debts of the debtor under the financial derivatives transaction documents, principal payable under the debt financing instrument or debt financing plan, bond principal, etc., all debt interest under the main contract, loan interest, interest payable under the debt financing instrument or debt financing plan, bond interest, etc. , the fees that the debtor should pay due to breach of contract under the main contract (including but not limited to: penalty interest, compound interest, fines, late fees, liquidated damages, damages), the fees for creditors to realize their claims (including but not limited to litigation/enforcement/arbitration fees, Preservation fees, guarantee fees, lawyer fees, investigation and evidence collection fees, notarization fees, announcement fees, travel expenses, appraisal fees, auction fees, property rights transfer taxes, etc.), doubled debt interest during the delayed performance of effective legal documents and other related reasonable expenses, etc. Even if the total debt amount exceeds the principal amount of the maximum creditor's right or the related interest and expenses are formed after the maximum creditor's right is determined, the guarantor shall not refuse to assume liability for the excess part on this basis. If the main contract is a contract for issuance of a letter of credit, the principal amount under the main contract shall be the sum of the issuance amount and the excess amount.
Guarantee period: (1) Three years from the expiration of the debt performance period under the independent contract. (2) There can be multiple main contracts corresponding to this contract. When the debt performance periods under different main contracts are different, for the debts under each main contract, the guarantee period of this contract is three years from the expiration date of the debt performance period under that main contract.
(2) Ningxia Delixin
Lender: Guyuan Branch of Shizuishan Bank Co., Ltd.
Borrower: Ningxia Delixin Pharmaceutical Co., Ltd.
Guarantor: Hunan Dajia Weikang Pharmaceutical Industry Co., Ltd.
Guarantee method: joint liability guarantee
Guaranteed maximum principal limit: RMB 20,000,000
Guarantee scope: In addition to the loan principal, it also includes interest, liquidated damages, penalty interest, compound interest, damages and all costs for realizing creditor's rights.
Guarantee period: from the date of loan disbursement to three years after the expiration of the loan performance period. If the loan is extended, the guarantee period will be calculated from the expiration of the extension period, and the guarantor will continue to bear joint and several liability for the extended loan in accordance with the guarantee method and period agreed in this contract.
(3) 10 stores under Shanxi Simile
Debtors: Shanxi Simile Pharmaceutical Chain Co., Ltd. Datong Beichen Garden Store, Shanxi Simile Pharmaceutical Chain Co., Ltd. Datong Fuxi Store, Shanxi Simile Pharmaceutical Chain Co., Ltd. Datong Jinxiang Store, Shanxi Simile Pharmaceutical Chain Co., Ltd. Datong Bureau East Store, Shanxi Simile Pharmaceutical Chain Co., Ltd. Datong Shuiquanwanlong Yuandian, Shanxi Simile Pharmaceutical Chain Co., Ltd. Datong Sun City Store, Shanxi Simile Pharmaceutical Chain Co., Ltd. Datong Tongquanli Store, Shanxi Simile Pharmaceutical Chain Co., Ltd. Datong Yingbin Garden Store, Shanxi Simile Pharmaceutical Chain Co., Ltd. Datong Yingze East Street Store, Shanxi Simile Pharmaceutical Chain Co., Ltd. Datong Yonghe Road Store
Creditor: Industrial Bank Co., Ltd. Datong Branch
Guarantor: Hunan Dajia Weikang Pharmaceutical Industry Co., Ltd.
Guarantee method: joint liability guarantee
Maximum debt amount: Shanxi Simile Pharmaceutical Chain Co., Ltd. Datong Beichen Garden Store is 3 million yuan, Shanxi Simile Pharmaceutical Chain Co., Ltd. Datong Fuxi Store is 3 million yuan, Shanxi Simile Pharmaceutical Chain Co., Ltd. is 3 million yuan Co., Ltd. Datong Jinxiang store is 200,000 yuan, Shanxi Simile Pharmaceutical Chain Co., Ltd. Datong Bureau East store is 3 million yuan, Shanxi Simile Pharmaceutical Chain Co., Ltd. Datong Shuiquanwan Longyuan store is 250,000 yuan Yuan, Shanxi Simile Pharmaceutical Chain Co., Ltd. Datong Sun City Store is 3 million yuan, Shanxi Simile Pharmaceutical Chain Co., Ltd. Datong Tongquanli store is 200,000 yuan, Shanxi Simile Pharmaceutical Chain Co., Ltd. The Datong Yingbin Park store is priced at RMB 200,000, the Datong Yingze East Street store of Shanxi Simile Pharmaceutical Chain Co., Ltd. is priced at RMB 250,000, and the Datong Yonghe Road store of Shanxi Simile Pharmaceutical Chain Co., Ltd. is priced at RMB 3 million.
Scope of guarantee: (1) The creditor's rights guaranteed by this contract (hereinafter referred to as "guaranteed creditor's rights") are all the creditor's rights formed against the debtor by providing various loans, financing, guarantees and other on- and off-balance sheet financial services to the debtor in accordance with the main contract, including but not limited to the creditor's principal, interest (including penalty interest and compound interest), liquidated damages, damages, and the creditor's expenses for realizing the creditor's rights, etc. (2) The creditor's claims against the debtor that already existed before the guarantee amount of this contract began to be calculated and that both parties to this contract agreed to transfer to the maximum amount of guarantee agreed in this contract. (3) During the validity period of the guarantee line, the creditor handles trade financing, acceptance, bill repurchase, guarantee and other financing businesses for the debtor. The creditor's claims against the debtor that occur after the guarantee limit is valid due to the debtor's refusal to pay, creditor advances, etc. also constitute part of the guaranteed creditor's rights. (4) The principal, interest, other expenses, performance period, purpose, rights and obligations of the parties and any other related matters that the creditor enjoys due to the debtor's handling of various financings, guarantees and other on- and off-balance sheet financial businesses under the main contract shall be subject to the records of the relevant agreements, contracts, applications, notices, various vouchers and other relevant legal documents under the main contract, and the issuance or signing of the relevant agreements, contracts, applications, notices, various vouchers and other relevant legal documents does not require confirmation by the guarantor. (5) To avoid ambiguity, all fees and expenses incurred by the creditor in connection with the preparation, perfection, performance or enforcement of this contract or the exercise of rights under this contract (including but not limited to attorney fees, litigation (arbitration) fees, fees for applying to a notary public for issuance of an execution certificate, etc.) shall constitute part of the guaranteed creditor's rights.
Guarantee period: (1) The guarantee period is calculated separately based on each financing provided by the creditor to the debtor under the main contract. For each financing, the guarantee period is three years from the expiration date of the debt performance period under the financing. (2) If the financing specified in a single main contract expires in batches, the guarantee period of each batch of debt is three years from the expiration date of each batch of financing performance period. (3) If the main creditor's rights are repaid in installments, the guarantee period for each creditor's right will also be calculated in installments. The guarantee period is three years from the maturity date of each creditor's right. (4) If the creditor and the debtor reach an extension agreement for any financing under the main contract, the guarantor hereby irrevocably acknowledges and agrees to the extension, and the guarantor will still bear joint and several liability for each financing under the main contract as stipulated in this contract. For each extended financing, the guarantee period is three years from the expiration date of the debt performance period re-agreed in the extension agreement. (5) If the creditor declares that the debt is due early in accordance with the provisions of laws and regulations or the main contract, the guarantee period is three years from the date of expiration of the debt performance period notified by the creditor to the debtor. (6) The guarantee period under bank acceptance bills, letters of credit and letters of guarantee is three years from the date the creditor advances the money. If advances are made in installments, the guarantee period is calculated separately from the date of each advance. (7) The guarantee period for commercial bill discounting is three years from the maturity date of the discounted bill. (8) For other on- and off-balance sheet financial businesses provided by the creditor to the debtor, three years will begin from the expiration of the debt performance period under the financial business.
5. Cumulative number of external guarantees and number of overdue guarantees
As of the disclosure date of this announcement, the total amount of guarantees provided by the company and its holding subsidiaries is RMB 2.50 billion, accounting for 168.03% of the company's latest audited net assets; the total balance of guarantees provided by the company and its holding subsidiaries is RMB 1,601.9598 million, accounting for 107.67% of the company's latest audited net assets.
Among them, the total amount of the company's guarantee line for its wholly-owned subsidiary Dajia Pharmaceutical is 1.48 billion yuan, accounting for 99.47% of the company's latest audited net assets. The company's cumulative total guarantee balance for Dajia Medicine is 1.1501634 million yuan, accounting for 77.30% of the company's most recent audited net assets; the company's total guarantee line for its holding subsidiary Ningxia Delixin is 25,000.00 Ten thousand yuan, accounting for 16.80% of the company's latest audited net assets; the total balance of guarantees provided by the company to Ningxia Delixin is 206.0682 million yuan, accounting for 13.85% of the company's latest audited net assets; the company's total guarantee line for its controlled subsidiary Shanxi Simile is 200,000,000 yuan, accounting for 10% of the company's latest audited net assets 13.44%; the total balance of guarantees provided by the company to Shanxi Simile is 79.25 million yuan, accounting for 5.33% of the company's latest audited net assets. The company and its controlled subsidiaries do not provide guarantees to units outside the consolidated statements, there are no overdue guarantees, there are no guarantee matters involving litigation, and there is no situation where the company should bear losses due to a judgment against the guarantee.
6. Documents for reference
The "Changsha Bank Maximum Guarantee Contract" signed between the company and Changsha Bank Co., Ltd.;
The "Liquid Capital Loan Contract" signed between the company and Guyuan Branch of Shizuishan Bank Co., Ltd.;
The "Maximum Guarantee Contract" signed by the company with Datong Branch of Industrial Bank Co., Ltd. (Shanxi Simile Pharmaceutical Chain Co., Ltd. Datong Beichen Garden Store, Shanxi Simile Pharmaceutical Chain Co., Ltd. Datong Fu West Store, Shanxi Simile Pharmaceutical Chain Co., Ltd. Datong Jinxiang Store, Shanxi Simile Pharmaceutical Chain Co., Ltd. Datong Bureau East Store, Shanxi Simile Pharmaceutical Chain Co., Ltd. Datong Bureau East Store, Shanxi Simile Pharmaceutical Chain Co., Ltd. Datong Bureau East Store) Industrial Chain Co., Ltd. Datong Shuiquanwan Longyuan Store, Shanxi Simile Pharmaceutical Chain Co., Ltd. Datong Sun City Store, Shanxi Simile Pharmaceutical Chain Co., Ltd. Datong Tongquanli Store, Shanxi Simile Pharmaceutical Chain Co., Ltd. Datong Yingbinyuan Store, Shanxi Simile Pharmaceutical Chain Co., Ltd. Datong Yingze East Street Store, Shanxi Simile Pharmaceutical Chain Co., Ltd. Datong Yonghe Road Store).
Announcement is hereby made.
Board of Directors of Hunan Dajia Weikang Pharmaceutical Industry Co., Ltd.
July 31, 2026